Clinical Trial Update: Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating azacitidine with entinostat in patients with Stage I non-small cell lung cancer after surgical removal; the study was terminated and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Entinostat (entinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2019-02-05